Actos Tablets Special Drug Use Surveillance 'Combined Use of Insulin Products / Long-term Treatment'
Phase of Trial: Phase IV
Latest Information Update: 14 Mar 2019
Price : $35 *
At a glance
- Drugs Pioglitazone (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Takeda
- 31 Aug 2018 Biomarkers information updated
- 25 Aug 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 27 Feb 2014 New trial record